Thalidomide shows promising results in patients with multiple myeloma.
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D009101:Multiple Myeloma / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents; D013792:Thalidomide